Companies

Coherus Oncology, Inc. (CHRS) SEC filings

CIK 0001512762 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)
Net income (USD)-291.8 M-287.1 M132.2 M
Diluted EPS (USD/shares)1.43-3.76-3.81

Latest filings

FiledFormDescriptionPeriod
2026-08-288-K8-K items 8.01,9.012026-08-28
2026-08-28424B5424B5
2026-08-28424B3424B3
2026-08-178-K8-K items 7.01,8.01,9.012026-08-17
2026-08-178-K8-K items 1.01,1.02,2.03,9.012026-08-17
2026-08-05S-8S-8
2026-08-0510-Q10-Q2026-06-30
2026-08-058-K8-K items 2.02,9.012026-08-05
2026-07-27SCHEDULE 13GSCHEDULE 13G
2026-06-158-K8-K items 4.01,9.012026-06-12
2026-06-09442026-06-05
2026-06-09442026-06-05
2026-06-09442026-06-05
2026-06-09442026-06-05
2026-06-09442026-06-05
2026-06-09442026-06-05
2026-06-09442026-06-05
2026-06-024OWNERSHIP DOCUMENT2026-05-29
2026-06-024OWNERSHIP DOCUMENT2026-05-29
2026-06-018-K8-K items 5.072026-05-27
2026-05-28DEFA14ADEFA14A
2026-05-15SCHEDULE 13G/ASCHEDULE 13G/A
2026-05-1110-Q10-Q2026-03-31
2026-05-118-K8-K items 2.02,9.012026-05-11
2026-05-11SCHEDULE 13G/ASCHEDULE 13G/A

Forms on file (last 1,000): 4 344, 8-K 196, SC 13G/A 51, 3 36, 10-Q 36, S-8 23, DEFA14A 23, SC 13G 20. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=CHRS (0.002 USD), /gw/filings/filings?ticker=CHRS&form=8-K, /gw/filings/facts?ticker=CHRS&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange